This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Pathological findings after radical prostatectomy in men eligible for active surveillance (French trial SURACAP): Is the misclassification rate acceptable? - Abstract
May 3, 2011
Editor's Commentary - Association of obesity with prostate cancer: A case-control study within the population-based PSA testing phase of the ProtecT study
May 3, 2011
EAU 2011 - Open radical prostatectomy (ORP) performed by low volume surgeons predisposes to higher rates of venous thrombosis (VT) and pulmonary embolism (PE) - Session Highlights
May 3, 2011
EAU 2011 - Influence of high dose low molecular weight heparin (LMWH) on blood transfusion and lymphocele rate in open radical prostatectomy - Session Highlights
May 3, 2011
EAU 2011 - Combining screening and chemoprevention of prostate cancer - Session Highlights
May 3, 2011
EAU 2011 - Results from the Gothenburg randomized prostate cancer screening trial - Session Highlights
May 3, 2011
The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers - Abstract
May 2, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy - Abstract
May 2, 2011
Avoiding androgen deprivation therapy in men with high-risk prostate cancer: The role of radical prostatectomy as initial treatment - Abstract
May 2, 2011
Prostate cancer treatment ascertained from several sources: Analysis of disagreement and error - Abstract
May 2, 2011
Factors associated with downgrading in patients with high grade prostate cancer - Abstract
May 2, 2011
A longitudinal study of changes in provider-patient interaction in treatment of localized prostate cancer - Abstract
May 2, 2011
Comorbidity and competing risks for mortality in men with prostate cancer - Abstract
May 2, 2011
Prostate cancer stem cells and their potential roles in metastasis - Abstract
May 2, 2011
A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study - Abstract
May 2, 2011
Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins - Abstract
May 2, 2011
Contemporary management of postprostatectomy incontinence - Abstract
May 2, 2011
EAU 2011 - Antibiotics and/or alpha blocker agents may decrease the PSA levels before biopsy but not detection rate of prostate cancer - Session Highlights
May 2, 2011
EAU 2011 - Metabolic syndrome and prostate cancer: A possible link to prostate cancer aggressiveness - Session Highlights
May 2, 2011
EAU 2011 - Periprostatic fat pads harbor lymph nodes and lymph node metastases: Impact on pathological work up - Session Highlights
May 1, 2011
Page 1417 of 1447
Start
Prev
1412
1413
1414
1415
1416
1417
1418
1419
1420
1421
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free